By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure Biosciences and Target Discovery have struck a multi-faceted agreement covering the development, manufacture, and co-marketing of reagents, PBI said today.

Under the agreement, TDI has licensed PBI to make and sell a line of TDI reagents that were designed to be used with PBI's Pressure Cycling Technology for preparing tissues for scientific analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: factors affecting the success of whole-genome sequencing for routine clinical diagnosis, and more.

A large meta-analysis from an international team reports that nature and nurture have about an equal overall influence on human traits.

The Lasker Foundation's Claire Pomeroy laments the state of NIH funding at Forbes.

Social media is changing how scientists discuss research, as tweets from University of Chicago's Yoav Gilad about a Mouse ENCODE paper have shown, Nature reports.